ELV vs PINC: fair value comparison
Elevance Health, Inc. and Premier, Inc. · Updated 2026-10-19
PINC has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, ELV currently ranks higher by quality score.
| ELV | PINC | |
|---|---|---|
| Verdict | Fairly valued | No estimate yet |
| Last price | $412.70 | $49.24 |
| 12-month range | $280.74–$428.43 | $49.05–$49.80 |
| Rank by discount to fair value | #64 of 108 Healthcare | — |
| Rank by quality score | #113 of 301 Healthcare | #115 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Expanding |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: ELV fair value analysis · PINC fair value analysis